Spots Global Cancer Trial Database for stage iii adult hodgkin lymphoma
Every month we try and update this database with for stage iii adult hodgkin lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease | NCT00176475 | Leukemia Lymphoma Multiple Myelom... | rituximab therapeutic all... | 18 Years - | Rutgers, The State University of New Jersey | |
| Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma | NCT00981097 | Lymphoma Nonneoplastic C... | polymerase chai... laboratory biom... | 18 Years - | AIDS Malignancy Consortium | |
| Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma | NCT01165645 | Hodgkin Lymphom... Stage I Adult H... Stage II Adult ... Stage III Adult... Stage IV Adult ... | lopinavir ritonavir polymerase chai... flow cytometry enzyme-linked i... laboratory biom... | 18 Years - | Mayo Clinic | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | NCT00002522 | Lymphoma | cisplatin cyclophosphamid... etoposide autologous bone... bone marrow abl... peripheral bloo... syngeneic bone ... radiation thera... | 15 Years - 70 Years | Temple University | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | NCT00003389 | Lymphoma | Doxorubicin Bleomycin Vinblastine Dacarbazine Vincristine Mechlorethamine Etoposide Prednisone Cyclophosphamid... Radiotherapy | 16 Years - | Eastern Cooperative Oncology Group | |
| Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers | NCT00003572 | Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | peripheral bloo... mycophenolate m... tacrolimus allogeneic bone... radiation thera... | 18 Years - 70 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma | NCT00369681 | Lymphoma | Bleomycin Rituximab Dacarbazine Doxorubicin Vinblastine | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer | NCT00296023 | Chronic Myelopr... Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | anti-thymocyte ... filgrastim therapeutic all... busulfan fludarabine pho... methotrexate tacrolimus nonmyeloablativ... peripheral bloo... | 18 Years - 75 Years | University of California, San Francisco | |
| Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma | NCT00265889 | Lymphoma | filgrastim busulfan cyclophosphamid... etoposide melphalan autologous-auto... radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy | NCT00003341 | Anemia Leukemia Lymphoma Multiple Myelom... | epoetin alfa quality-of-life... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma | NCT00389506 | Lymphoma | LMB-2 immunotox... cyclophosphamid... fludarabine pho... pharmacological... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer | NCT00782379 | Leukemia Lymphoma Myelodysplastic... | busulfan cyclophosphamid... fludarabine pho... mycophenolate m... tacrolimus allogeneic hema... peripheral bloo... | 18 Years - 60 Years | Northside Hospital, Inc. | |
| Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy | NCT01319526 | Lymphoma Nonneoplastic C... | DNA analysis RNA analysis laboratory biom... | 18 Years - | AIDS Malignancy Consortium | |
| Tipifarnib in Treating Patients With Advanced Hematologic Cancer | NCT00005967 | Chronic Myelopr... Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years | NCT00079105 | Lymphoma | bleomycin sulfa... cyclophosphamid... etoposide mitoxantrone hy... prednisolone procarbazine hy... vinblastine sul... | 60 Years - 120 Years | Newcastle-upon-Tyne Hospitals NHS Trust | |
| S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma | NCT00822120 | Lymphoma Nonneoplastic C... | bleomycin sulfa... filgrastim ABVD regimen BEACOPP regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... | 18 Years - 60 Years | SWOG Cancer Research Network | |
| Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer | NCT00004061 | Leukemia Lymphoma Oral Complicati... | filgrastim palifermin cyclophosphamid... etoposide ifosfamide peripheral bloo... quality-of-life... radiation thera... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | NCT00005613 | Lymphoma | cyclophosphamid... etoposide BCNU | 15 Years - 55 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy | NCT00006220 | Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | arsenic trioxid... tretinoin | 15 Years - | Washington University School of Medicine | |
| Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer | NCT00004061 | Leukemia Lymphoma Oral Complicati... | filgrastim palifermin cyclophosphamid... etoposide ifosfamide peripheral bloo... quality-of-life... radiation thera... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease | NCT00002462 | Lymphoma | bleomycin sulfa... doxorubicin hyd... mechlorethamine... prednisone procarbazine hy... vinblastine sul... vincristine sul... low-LET cobalt-... low-LET photon ... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy | NCT01319526 | Lymphoma Nonneoplastic C... | DNA analysis RNA analysis laboratory biom... | 18 Years - | AIDS Malignancy Consortium | |
| Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | NCT00041210 | Lymphoma | bleomycin sulfa... ABVD regimen Stanford V regi... dacarbazine doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | NCT00003389 | Lymphoma | Doxorubicin Bleomycin Vinblastine Dacarbazine Vincristine Mechlorethamine Etoposide Prednisone Cyclophosphamid... Radiotherapy | 16 Years - | Eastern Cooperative Oncology Group | |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma | NCT01476410 | Adult Lymphocyt... Adult Lymphocyt... Adult Mixed Cel... Adult Nodular S... Stage II Adult ... Stage III Adult... Stage IV Adult ... | brentuximab ved... doxorubicin hyd... vinblastine dacarbazine quality-of-life... DNA analysis RNA analysis fludeoxyglucose... positron emissi... laboratory biom... immunohistochem... polymorphism an... | 60 Years - | Northwestern University | |
| RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease | NCT00002462 | Lymphoma | bleomycin sulfa... doxorubicin hyd... mechlorethamine... prednisone procarbazine hy... vinblastine sul... vincristine sul... low-LET cobalt-... low-LET photon ... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | NCT00678327 | Lymphoma | bleomycin sulfa... filgrastim pegfilgrastim cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisolone procarbazine hy... vinblastine sul... vincristine sul... | 18 Years - 100 Years | University College, London | |
| Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma | NCT00478062 | Lymphoma | Hodgkin's antig... adjuvant therap... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | NCT00002522 | Lymphoma | cisplatin cyclophosphamid... etoposide autologous bone... bone marrow abl... peripheral bloo... syngeneic bone ... radiation thera... | 15 Years - 70 Years | Temple University | |
| Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas | NCT02213913 | Adult Grade III... B-cell Chronic ... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Cutaneous B-cel... Extranodal Marg... Intraocular Lym... Nodal Marginal ... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Progressive Hai... Small Intestine... Splenic Margina... Stage 0 Chronic... Stage I Adult D... Stage I Adult D... Stage I Adult D... Stage I Adult H... Stage I Adult I... Stage I Chronic... Stage I Grade 1... Stage I Grade 2... Stage I Grade 3... Stage I Mantle ... Stage I Margina... Stage I Small L... Stage II Adult ... Stage II Chroni... Stage II Small ... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Chron... Stage III Grade... Stage III Grade... Stage III Grade... Stage III Mantl... Stage III Margi... Stage III Small... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Chroni... Stage IV Grade ... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Testicular Lymp... Untreated Hairy... Waldenström Mac... | lenalidomide etoposide prednisone vincristine sul... doxorubicin hyd... cyclophosphamid... rituximab quality-of-life... laboratory biom... | 18 Years - | University of Chicago | |
| Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma | NCT00265889 | Lymphoma | filgrastim busulfan cyclophosphamid... etoposide melphalan autologous-auto... radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | NCT00041210 | Lymphoma | bleomycin sulfa... ABVD regimen Stanford V regi... dacarbazine doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer | NCT00004132 | Drug/Agent Toxi... Leukemia Lymphoma Multiple Myelom... Oral Complicati... Radiation Toxic... | filgrastim palifermin cyclophosphamid... etoposide ifosfamide quality-of-life... radiation thera... | 12 Years - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma | NCT00002715 | Lymphoma | Bleomycin sulfa... Stanford V regi... Doxorubicin hyd... Etoposide Mechlorethamine... Prednisone Vinblastine Vincristine sul... | 18 Years - 60 Years | Stanford University | |
| HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection | NCT02343666 | Human Immunodef... Stage I Adult H... Stage I Adult N... Stage II Adult ... Stage II Adult ... Stage III Adult... Stage III Adult... Stage IV Adult ... Stage IV Adult ... | C46/CCR5/P140K ... Carmustine Filgrastim Laboratory Biom... O6-Benzylguanin... Plerixafor | 18 Years - 66 Years | Fred Hutchinson Cancer Center | |
| Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma | NCT00389506 | Lymphoma | LMB-2 immunotox... cyclophosphamid... fludarabine pho... pharmacological... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | NCT00005613 | Lymphoma | cyclophosphamid... etoposide BCNU | 15 Years - 55 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | NCT00006373 | Lymphoma | etoposide ifosfamide topotecan hydro... autologous bone... Mesna | 18 Years - 64 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers | NCT00619645 | Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | busulfan cyclosporine fludarabine pho... mycophenolate m... allogeneic hema... peripheral bloo... | 18 Years - 120 Years | University of California, Davis | |
| Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy | NCT00003341 | Anemia Leukemia Lymphoma Multiple Myelom... | epoetin alfa quality-of-life... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer | NCT00296023 | Chronic Myelopr... Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | anti-thymocyte ... filgrastim therapeutic all... busulfan fludarabine pho... methotrexate tacrolimus nonmyeloablativ... peripheral bloo... | 18 Years - 75 Years | University of California, San Francisco | |
| Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers | NCT00003572 | Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | peripheral bloo... mycophenolate m... tacrolimus allogeneic bone... radiation thera... | 18 Years - 70 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma | NCT00920153 | Lymphoma | bleomycin sulfa... ABVD regimen carmustine cisplatin cytarabine dacarbazine dexamethasone doxorubicin hyd... etoposide gemcitabine hyd... ifosfamide melphalan methylprednisol... mitoguazone vincristine sul... vindesine vinorelbine tar... allogeneic hema... autologous hema... | 18 Years - 65 Years | French Innovative Leukemia Organisation | |
| Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma | NCT00288067 | Adult Nodular L... B-cell Chronic ... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Stage II Margin... Stage II Small ... Extranodal Marg... Nodal Marginal ... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Refractory Chro... Splenic Margina... Stage I Adult B... Stage I Adult D... Stage I Adult H... Stage I Adult L... Stage I Chronic... Stage I Grade 1... Stage I Grade 2... Stage I Small L... Stage II Adult ... Stage II Chroni... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Chron... Stage III Grade... Stage III Grade... Stage III Mantl... Stage III Margi... Stage III Small... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Chroni... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Waldenström Mac... | fenretinide rituximab | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer | NCT00004145 | Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | anti-thymocyte ... cyclophosphamid... fludarabine pho... peripheral bloo... | 18 Years - 60 Years | University of Chicago |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
